PLK3-IN-1
PLK3-IN-1 is a selective Polo-like kinase 3 (PLK3) inhibitor with a human PLK3 IC50 of 5 nM. PLK3-IN-1 can be used for cancer research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C27H29FN8O
- Masse moléculaire:500.57
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
PLK3-IN-1 (Compound 9) potently inhibits purified PLK3 with an IC50 of 0.005 μM, and exhibits 1000-fold selectivity over PLK1 and 60-fold selectivity over PLK2 in a biochemical kinase inhibition assay[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Masse moléculaire 500.57
-
Formule C27H29FN8O
-
SMILES
CN1CCC[C@H](C1)C2=CNC3=CC=C(C=C32)NC4=NC=C(C(N5CCN(C(C5)=O)C6=CC=CC=N6)=N4)F
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)